These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9351060)

  • 1. What have we learned from the HOT (Hypertension Optimal Treatment) study?
    Ruilope LM; Hansson L; Zanchetti A
    Nephrol Dial Transplant; 1997 Oct; 12(10):2047-8. PubMed ID: 9351060
    [No Abstract]   [Full Text] [Related]  

  • 2. J-curve not burned off by HOT study. Hypertension Optimal Treatment.
    Kaplan N
    Lancet; 1998 Jun; 351(9118):1748-9. PubMed ID: 9635941
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of arterial hypertension: does it modify cardiovascular morbidity and mortality?].
    Godin M; Legallicier B
    Rev Med Interne; 2002 May; 23 Suppl 1():10s-12s. PubMed ID: 12108186
    [No Abstract]   [Full Text] [Related]  

  • 4. Advancing the science of aspirin in primary prevention of vascular events.
    Cardiovasc J Afr; 2007; 18(5):347-8. PubMed ID: 17985039
    [No Abstract]   [Full Text] [Related]  

  • 5. Aspirin for primary prevention of cardiovascular and all-cause mortality events in diabetes: updated meta-analysis of randomized controlled trials.
    Kunutsor SK; Seidu S; Khunti K
    Diabet Med; 2017 Mar; 34(3):316-327. PubMed ID: 27086572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex-related differences in response to aspirin in cardiovascular disease: an untested hypothesis.
    Hennekens CH; Hollar D; Baigent C
    Nat Clin Pract Cardiovasc Med; 2006 Jan; 3(1):4-5. PubMed ID: 16391594
    [No Abstract]   [Full Text] [Related]  

  • 7. Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials.
    Berger JS; Krantz MJ; Kittelson JM; Hiatt WR
    JAMA; 2009 May; 301(18):1909-19. PubMed ID: 19436018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Aspirin for primary prevention of asymptomatic atherosclerosis].
    Lévesque H
    J Mal Vasc; 2002 Dec; 27(5):263-6. PubMed ID: 12525771
    [No Abstract]   [Full Text] [Related]  

  • 9. [Results of the Women's Health Study].
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; (Suppl 14):54-5. PubMed ID: 16184856
    [No Abstract]   [Full Text] [Related]  

  • 10. Aspirin for the prevention of cardiovascular events in patients without clinical cardiovascular disease: a meta-analysis of randomized trials.
    Berger JS; Lala A; Krantz MJ; Baker GS; Hiatt WR
    Am Heart J; 2011 Jul; 162(1):115-24.e2. PubMed ID: 21742097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The HOT study].
    Klovning A; Sandvik H; Straand J
    Tidsskr Nor Laegeforen; 1999 Jan; 119(3):407. PubMed ID: 10074841
    [No Abstract]   [Full Text] [Related]  

  • 12. Aspirin therapy in primary prevention: comment on "effect of aspirin on vascular and nonvascular outcomes".
    Mora S
    Arch Intern Med; 2012 Feb; 172(3):217-8. PubMed ID: 22231608
    [No Abstract]   [Full Text] [Related]  

  • 13. Aspirin prophylaxis in people without prior cardiovascular disease does not lead to reductions in cardiovascular death or cancer mortality.
    Farooq MU; Gorelick PB
    Evid Based Med; 2013 Apr; 18(2):e14. PubMed ID: 22851620
    [No Abstract]   [Full Text] [Related]  

  • 14. Aspirin is beneficial in hypertensive patients with chronic kidney disease: a post-hoc subgroup analysis of a randomized controlled trial.
    Jardine MJ; Ninomiya T; Perkovic V; Cass A; Turnbull F; Gallagher MP; Zoungas S; Lambers Heerspink HJ; Chalmers J; Zanchetti A
    J Am Coll Cardiol; 2010 Sep; 56(12):956-65. PubMed ID: 20828648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Aspirin in primary prevention of cardiovascular events in women and men (a meta-analysis of randomized controlled trials)].
    Iavelov IS
    Kardiologiia; 2006; 46(3):75-6. PubMed ID: 16710263
    [No Abstract]   [Full Text] [Related]  

  • 16. [Primary prevention of cardiovascular disease].
    Gohlke H
    Dtsch Med Wochenschr; 2005 Jan; 130(1-2):38-43. PubMed ID: 15619173
    [No Abstract]   [Full Text] [Related]  

  • 17. [I Brazilian Guidelines for cardiovascular prevention].
    Simão AF; Precoma DB; Andrade JP; Correa FH; Saraiva JF; Oliveira GM; Murro AL; Campos A; Alessi A; Avezum A; Achutti AC; Miguel AC; Sousa AC; Lotemberg AM; Lins AP; Falud AA; Brandão AA; Sanjuliani AF; Sbissa AS; Alencar FA; Herdy AH; Polanczyk CA; Lantieri CJ; Machado CA; Scherr C; Stoll C; Amodeo C; Araújo CG; Saraiva D; Moriguchi EH; Mesquita ET; Fonseca FA; Campos GP; Soares GP; Feitosa GS; Xavier HT; Castro I; Giuliano IC; Rivera IV; Guimaraes IC; Issa JS; Souza JR; Faria NJ; Cunha LB; Pellanda LC; Bortolotto LA; Bertolami MC; Miname MH; Gomes MA; Tambascia M; Malachias MV; Silva MA; Izar MC; Magalhães ME; Bacellar MS; Milani M; Wajngarten M; Ghorayeb N; Coelho OR; Villela PB; Jardim PC; Santos Filho RD; Stein R; Cassani RS; D'Avila RI; Ferreira RM; Barbosa RB; Povoa RM; Kaiser SE; Ismael SC; Carvalho T; Giraldez VZ; Coutinho W; Souza WK;
    Arq Bras Cardiol; 2013 Dec; 101(6 Suppl 2):1-63. PubMed ID: 24554026
    [No Abstract]   [Full Text] [Related]  

  • 18. AAA- a further step towards a moratorium for aspirin in the primary prevention.
    Minar E
    Vasa; 2010 May; 39(2):119-122. PubMed ID: 20521434
    [No Abstract]   [Full Text] [Related]  

  • 19. Aspirin for the Primary Prevention of Cardiovascular Disease: In Need of Clarity.
    Miedema MD; Huguelet J; Virani SS
    Curr Atheroscler Rep; 2016 Jan; 18(1):4. PubMed ID: 26753770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspirin in the prevention of cancer.
    Wald NJ; Morris JK; Law MR
    Lancet; 2011 May; 377(9778):1649; author reply 1651-2. PubMed ID: 21571138
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.